pharma · Acute Ischemic Stroke · Chronic Kidney Disease · DMAC
DiaMedica Therapeutics
DiaMedica Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Minneapolis, USA HQ
45 Employees
Public company Type
DMAC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Minneapolis, USA
- Employees
- 45
- Programs
- 8
- Drugs
- 7
- Patents
- 9
DiaMedica Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to DiaMedica Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
DiaMedica Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for DiaMedica Therapeutics.
-
DM199-2021-001 — Phase 3
Clinical update -
Recombinant human tissue kallikrein — Phase 1
Clinical update -
Recombinant human tissue kallikrein — Phase 3
Clinical update -
Recombinant human tissue kallikrein — Phase 2
Clinical update -
DM199 — Unknown
Clinical update -
DM199 — Phase 2
Clinical update -
DM199 — Phase 2
Clinical update -
DM199 — Phase 1
Clinical update